<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Haleon Plc — News on 6ix</title>
<link>https://6ix.com/company/haleon-plc</link>
<description>Latest news and press releases for Haleon Plc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 16 Mar 2026 07:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/haleon-plc" rel="self" type="application/rss+xml" />
<item>
<title>Transactions in Own Shares</title>
<link>https://6ix.com/company/haleon-plc/news/transactions-in-own-shares-4</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/transactions-in-own-shares-4</guid>
<pubDate>Mon, 16 Mar 2026 07:00:00 GMT</pubDate>
<description>Haleon plc has announced the purchase of 2,749,486 ordinary shares for cancellation as part of its share buyback programme, with transactions occurring on March 12th and 13th, 2026. The weighted average prices paid per share ranged from 373.23p to 375.42p across various exchanges. Following these purchases, Haleon's registered share capital stands at 8,949,604,162 ordinary shares, with 8,905,952,489 shares carrying voting rights.
Disclaimer*</description>
</item>
<item>
<title>Publication of Annual Report 2025 & Notice of AGM</title>
<link>https://6ix.com/company/haleon-plc/news/publication-of-annual-report-2025-and-notice-of-agm</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/publication-of-annual-report-2025-and-notice-of-agm</guid>
<pubDate>Fri, 13 Mar 2026 14:00:00 GMT</pubDate>
<description>Haleon plc has published its Annual Report and Accounts and Form 20-F for 2025, along with the Notice of its 2026 Annual General Meeting, all of which are available on the company's website. The Annual Report and Form 20-F has also been filed with the US Securities and Exchange Commission. The 2026 AGM will be a virtual meeting held on Wednesday, 29 April 2026, at 3:00 PM BST, with full details and joining instructions provided in the Notice.
Disclaimer*</description>
</item>
<item>
<title>Commencement of £500m Share Buyback Programme</title>
<link>https://6ix.com/company/haleon-plc/news/commencement-of-pound500m-share-buyback-programme</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/commencement-of-pound500m-share-buyback-programme</guid>
<pubDate>Thu, 12 Mar 2026 10:00:00 GMT</pubDate>
<description>Haleon plc has commenced a share buyback programme to purchase ordinary shares up to an aggregate consideration of £500 million, with purchases to be carried out on the London Stock Exchange, CBoE Equities Europe, and/or Aquis. This programme, which began immediately and will end no later than 19 August 2026, aims to reduce the company's share capital and is in line with its capital allocation priorities. Purchases made before the 2026 Annual General Meeting will use authority granted at the 202</description>
</item>
<item>
<title>Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health</title>
<link>https://6ix.com/company/haleon-plc/news/haleon-strengthens-commitment-to-china-as-consumers-focus-on-better-everyday-health</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/haleon-strengthens-commitment-to-china-as-consumers-focus-on-better-everyday-health</guid>
<pubDate>Wed, 11 Mar 2026 18:40:00 GMT</pubDate>
<description>SHANGHAI, March 11, 2026--Haleon, a consumer company that is solely focused on better everyday health, is investing £65 million in a new state-of-the-art oral health manufacturing site in Shanghai. The facility will support the expansion of its oral care portfolio – which includes the global brands Sensodyne and parodontax – into China’s fast-growing tier 2 and tier 3 cities, where rising incomes, growing awareness of everyday health and a shift towards trusted, branded products are reshaping co</description>
</item>
<item>
<title>Total Voting Rights and Capital</title>
<link>https://6ix.com/company/haleon-plc/news/total-voting-rights-and-capital-12</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/total-voting-rights-and-capital-12</guid>
<pubDate>Mon, 02 Mar 2026 09:30:00 GMT</pubDate>
<description>Haleon plc has announced that as of February 28, 2026, its total issued share capital comprises 8,952,353,648 ordinary shares, with 43,969,144 held in treasury. Consequently, the number of ordinary shares carrying voting rights is 8,908,384,504, which shareholders and those with notification obligations should use as the denominator for calculating reportable interests under the FCA's Disclosure Guidance and Transparency Rules.
Disclaimer*</description>
</item>
<item>
<title>Haleon Preliminary 2025 Full Year Results</title>
<link>https://6ix.com/company/haleon-plc/news/haleon-preliminary-2025-full-year-results</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/haleon-preliminary-2025-full-year-results</guid>
<pubDate>Wed, 25 Feb 2026 07:00:00 GMT</pubDate>
<description>Haleon plc has released its preliminary full year results for 2025, announcing a proposed total dividend of 7.1p per ordinary share, representing a payout ratio of approximately 38% of adjusted earnings, and expects to grow its ordinary dividend at least in line with adjusted earnings, subject to market conditions and Board approval.
Disclaimer*</description>
</item>
<item>
<title>Director/PDMR Shareholding</title>
<link>https://6ix.com/company/haleon-plc/news/directorpdmr-shareholding-470</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/directorpdmr-shareholding-470</guid>
<pubDate>Thu, 12 Feb 2026 09:00:00 GMT</pubDate>
<description>Haleon plc has announced transactions by two Persons Discharging Managerial Responsibilities (PDMRs). On February 10, 2026, Adrian Morris, General Counsel, acquired 31 Partnership Shares at £3.956 each and was awarded 31 Matching Shares under the Share Reward Plan, totaling 62 ordinary shares. Jonathan Workman, President, Europe, also acquired 32 Partnership Shares at £3.956 each and was awarded 32 Matching Shares, totaling 64 ordinary shares. Both transactions occurred on the London Stock Excha</description>
</item>
<item>
<title>New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief</title>
<link>https://6ix.com/company/haleon-plc/news/sensodyne-clinical-repair-toothpaste-launches-150100738</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/sensodyne-clinical-repair-toothpaste-launches-150100738</guid>
<pubDate>Tue, 10 Feb 2026 15:01:00 GMT</pubDate>
<description>WARREN, N.J., February 10, 2026--The No. 1 dentist-recommended brand for sensitive teeth has launched Sensodyne Clinical Repair, its newest option for sensitive teeth, a toothpaste designed to address the root cause of tooth sensitivity. Based on data showing that 85% of people with sensitive teeth want solutions that repair sensitivity by addressing the root cause of their pain, Sensodyne developed Clinical Repair to go beyond temporary relief and actively repair sensitive areas of teeth with c</description>
</item>
<item>
<title>Director Declaration</title>
<link>https://6ix.com/company/haleon-plc/news/director-declaration-162</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/director-declaration-162</guid>
<pubDate>Wed, 21 Jan 2026 14:45:00 GMT</pubDate>
<description>Haleon plc announced that its Chief Financial Officer, Dawn Allen, will become the Chair of the Audit & Risk Committee of ITV plc effective March 5, 2026. Allen has been a Non-Executive Director and a member of ITV plc's Audit & Risk Committee since October 2, 2023. This notification is made in accordance with Listing Rule 6.4.9R(2).
Disclaimer*</description>
</item>
<item>
<title>Evolution of operating model</title>
<link>https://6ix.com/company/haleon-plc/news/evolution-of-operating-model</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/evolution-of-operating-model</guid>
<pubDate>Thu, 08 Jan 2026 13:30:00 GMT</pubDate>
<description>Haleon plc is evolving its operating model by mid-2026 to enhance growth and agility, aligning with its "Win as One" strategy. This involves creating a new Chief Growth Officer role responsible for category, marketing, strategy, and a global Commercial Excellence team, alongside six new Operating Units: Latin America, Middle East and Africa, Europe, India Subcontinent, Asia Pacific, and North America. A Chief Transformation Officer has also been appointed to oversee business process, operating m</description>
</item>
<item>
<title>TUMS Unveils Sweepstakes and Limited-Edition Burn Ball to Help Fans "Pass the TUMS" Ahead of Football's Big Game</title>
<link>https://6ix.com/company/haleon-plc/news/tums-unveils-sweepstakes-and-limited-edition-burn-ball-to-help-fans-pass-the-tums-ahead-of-footballs-big-game</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/tums-unveils-sweepstakes-and-limited-edition-burn-ball-to-help-fans-pass-the-tums-ahead-of-footballs-big-game</guid>
<pubDate>Tue, 06 Jan 2026 14:18:00 GMT</pubDate>
<description>One in four Big Game watchers experience occasional heartburn from their favorite foods — and 75% of those fans are unprepared, without relief on hand*. This year, ahead of football's biggest showdown, TUMS is debuting the first-ever Burn Ball — a limited-edition, custom-designed football, specifically engineered to pass the TUMS and deliver fast-acting heartburn relief on game day!</description>
</item>
<item>
<title>Board and Committee Changes</title>
<link>https://6ix.com/company/haleon-plc/news/board-and-committee-changes-1</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/board-and-committee-changes-1</guid>
<pubDate>Mon, 15 Dec 2025 10:00:00 GMT</pubDate>
<description>Haleon plc announced board and committee changes effective January 1, 2026, with Alan Stewart succeeding Vindi Banga as Senior Independent Director. Stewart, who joined the board in September 2024 as Chair of the Audit & Risk Committee, will retain this role and also serve on other committees. Vindi Banga will step down from the Audit & Risk and Remuneration Committees by December 31, 2025, and will become Chair of the Nominations & Governance Committee. Banga's remuneration as Chair will be £75</description>
</item>
<item>
<title>Haleon Recognized by Fast Company as a 2025 Brands That Matter Honoree</title>
<link>https://6ix.com/company/haleon-plc/news/haleon-recognized-by-fast-company-as-a-2025-brands-that-matter-honoree</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/haleon-recognized-by-fast-company-as-a-2025-brands-that-matter-honoree</guid>
<pubDate>Fri, 12 Dec 2025 14:26:00 GMT</pubDate>
<description>WARREN, N.J., December 12, 2025--Haleon, a global leader in consumer health, today announced it has been honored in Fast Company’s 2025 Brands That Matter list in the Family of Brands category, which highlights companies that created cultural moments for multiple brands across their portfolios. The annual list recognizes organizations that demonstrate cultural relevance, meaningful consumer connection, and a clear commitment to purpose.</description>
</item>
<item>
<title>Appointment of Vindi Banga as Chair</title>
<link>https://6ix.com/company/haleon-plc/news/appointment-of-vindi-banga-as-chair</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/appointment-of-vindi-banga-as-chair</guid>
<pubDate>Mon, 10 Nov 2025 07:00:00 GMT</pubDate>
<description>Haleon plc announced that Sir Dave Lewis will step down as Chair on December 31, 2025, to pursue a new executive role, and Vindi Banga will succeed him as Chair effective January 1, 2026. Banga, currently the Senior Independent Director, brings extensive global corporate and commercial leadership experience, including 33 years at Unilever and leadership roles at various portfolio companies of CD&R. The company confirmed no further information is required under UKLR 6.4.6R, and details regarding </description>
</item>
<item>
<title>Haleon 2025 Q3 Trading Statement</title>
<link>https://6ix.com/company/haleon-plc/news/haleon-2025-q3-trading-statement</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/haleon-2025-q3-trading-statement</guid>
<pubDate>Thu, 30 Oct 2025 07:00:00 GMT</pubDate>
<description>Haleon PLC has released its Q3 trading statement for the year ending December 31, 2025. The full statement is accessible on the company's website at www.haleon.com/investors and via the Financial Conduct Authority's National Storage Mechanism. An analyst and shareholder presentation, including a Q&A session, was hosted by the Chief Financial Officer on October 30, 2025, and an archived webcast will be available on the company's website.
Disclaimer*</description>
</item>
<item>
<title>Haleon Selects Salesforce Agentforce Life Sciences Cloud for Customer Engagement to Improve Engagement with Pharmacies and Healthcare Professionals with AI</title>
<link>https://6ix.com/company/haleon-plc/news/haleon-selects-salesforce-agentforce-life-sciences-cloud-for-customer-engagement-to-improve-engagement-with-pharmacies-and-healthcare-professionals-with-ai</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/haleon-selects-salesforce-agentforce-life-sciences-cloud-for-customer-engagement-to-improve-engagement-with-pharmacies-and-healthcare-professionals-with-ai</guid>
<pubDate>Wed, 08 Oct 2025 12:07:00 GMT</pubDate>
<description>LONDON & SAN FRANCISCO, October 08, 2025--Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world’s #1 AI CRM, today announced that Haleon will leverage Salesforce to drive more effective engagement with pharmacies and healthcare professionals worldwide.</description>
</item>
<item>
<title>Transaction in Own Shares & Buyback Update</title>
<link>https://6ix.com/company/haleon-plc/news/transaction-in-own-shares-and-buyback-update</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/transaction-in-own-shares-and-buyback-update</guid>
<pubDate>Thu, 02 Oct 2025 06:00:00 GMT</pubDate>
<description>Haleon plc announced on October 2, 2025, the purchase of 1,561,229 ordinary shares at £0.01 each, as part of its share buyback program's second tranche. The shares were purchased on October 1, 2025, at a highest price of 337.5000 pence and a lowest price of 331.9000 pence, with a volume-weighted average price of 335.0704 pence per share. The company intends to hold these shares as treasury shares. Following this transaction, Haleon's registered share capital is 8,952,353,648 ordinary shares of £</description>
</item>
<item>
<title>Transaction in Own Shares</title>
<link>https://6ix.com/company/haleon-plc/news/transaction-in-own-shares-256</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/transaction-in-own-shares-256</guid>
<pubDate>Wed, 01 Oct 2025 06:00:00 GMT</pubDate>
<description>Haleon PLC announced on October 1, 2025, the purchase of 1,500,000 ordinary shares of £0.01 each on September 30, 2025, under its share buyback program. The highest price paid per share was 333.3000p, and the lowest price was 328.4000p, with a volume-weighted average price of 331.3782p. The company intends to hold these shares as treasury shares. Following this transaction, Haleon's registered share capital is 8,952,353,648 ordinary shares of £0.01 each, with 44,400,783 held as treasury shares, </description>
</item>
<item>
<title>Holding(s) in Company</title>
<link>https://6ix.com/company/haleon-plc/news/holdings-in-company-513</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/holdings-in-company-513</guid>
<pubDate>Wed, 24 Sep 2025 14:00:00 GMT</pubDate>
<description>On September 24, 2025, Haleon PLC announced that Wellington Management Group LLP crossed a notifiable threshold regarding voting rights in the company. The resulting situation on September 23, 2025, shows Wellington Management Group's total voting rights at 4.98%, comprised of 4.69% voting rights attached to shares, representing 418,575,113 shares, and 0.29% through financial instruments, specifically depository receipts for 26,175,050 voting rights. This represents a slight decrease from the pr</description>
</item>
<item>
<title>TUMS helps Second Harvest tackle hunger in Canada for the fourth year in a row</title>
<link>https://6ix.com/company/haleon-plc/news/tums-helps-second-harvest-tackle-hunger-in-canada-for-the-fourth-year-in-a-row</link>
<guid isPermaLink="true">https://6ix.com/company/haleon-plc/news/tums-helps-second-harvest-tackle-hunger-in-canada-for-the-fourth-year-in-a-row</guid>
<pubDate>Tue, 02 Sep 2025 18:55:00 GMT</pubDate>
<description>Food waste is an avoidable problem, yet at least 10 million people continue to face food insecurity in Canada. In July 2025, StatsCan reported that the employment rate continued to drop, while also noting that there has been little net employment growth since the beginning of the year1. With numbers like this, it's evident that many Canadians are struggling financially, which is impacting their ability to feed themselves and their families. Meanwhile, 46.5 per cent2 of all food in Canada is wast</description>
</item>
</channel>
</rss>